Week in Washington 090122

Week in Washington is brought to you by Michael Cohen, PhD. Tune in each week to read the latest on healthcare policy and get a glimpse of what’s on the horizon.

Week in Washington


US Life Expectancy Plunges Again

For the second year in a row, US life expectancy declined. The average life span in the US was about a year shorter. In 2019, Americans were living almost 3 years longer than they were in 2022. Covid and overdose related deaths were the primary reasons for the decline. The declines are the largest in over a year. Native Americans experienced the sharpest decline, which was 6.6 years over the past two years.

 Chart shows change in life expectancy at birth since 2000

Covid Boosters Officially Approved

The FDA officially approved new boosters, which were designed specifically for the Omicron variant. Both Pfizer and Moderna boosters were approved. Individuals over 12 will be eligible for the booster and have not been infected/gotten in the last 2 months. The vaccine should be available starting next week.

Medicaid Eligibility Rules

CMS proposed rules that would change eligibility rules for Medicaid and CHIP. The rules, if finalized as proposed, would make it easier to obtain Medicaid coverage via standardizing eligibility and enrollment policies across states and reducing application challenging.


CMS announced that it would be making the largest ever investment into navigators (nearly $100 million). Navigators assist consumers to find coverage in the Exchanges and Medicaid programs. Navigator outreach has been shown to increase enrollment so the funding could have a material impact on the upcoming Open Enrollment.

Previous editions: 

08/25/2022: Week in Washington

08/18/2022: Week in Washington

08/04/2022: Week in Washington

07/28/2022: Week in Washington


07/14/2022: Week in Washington

07/07/2022: Week in Washington

06/29/2022: Week in Washington

06/23/2022: Week in Washington

Read More Wakely Insights
©2017-2022 Wakely Consulting Group LLC  All Rights Reserved. The materials in this document represent the opinion of the authors and are not representative of the views of Wakely Consulting Group. Wakely does not certify the information, nor does it guarantee the accuracy and completeness of such information. Use of this information is voluntary.